World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 9 January 2023
Main ID:  ISRCTN77313697
Date of registration: 20/11/2015
Prospective Registration: No
Primary sponsor: Lamhess
Public title: Long-term effect of physical activity intervention promoting autonomous practice
Scientific title: Protocol of the “As du Coeur” study: A randomized controlled trial on the maintenance of physical activity for cardiovascular patients
Date of first enrolment: 10/07/2014
Target sample size: 50
Recruitment status: Completed
URL:  https://www.isrctn.com/ISRCTN77313697
Study type:  Interventional
Study design:  Multi-centre interventional randomized controlled trial (Prevention)  
Phase:  Not Applicable
Countries of recruitment
France
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Marion    Fournier
Address:  261 route de grenoble 06000 NICE France
Telephone: +33 6 43 75 91 98
Email: fou2marion@gmail.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
1. Aged 18 years or over
2. Registered with chronic disease (cardiovascular disease or cardiac deficiency)
3. Considered as sedentary according to the brief physical activity assessment
4. Absence of contraindication to PA stated by a cardiologist
5. Possibility to attend a fitness center for a 60-min session twice a week

Exclusion criteria: Contraindication to PA stated by a cardiologist.

Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Cardiovascular disease
Circulatory System
Cardiovascular disease
Intervention(s)

Cardiovascular patients will be individually randomized in two groups.

Group 1: Participants will have two supervised physical activity sessions per week for 20 weeks. They will receive two supervised sessions over a period of 5 months., including one session of one hour of cardio-training and one session of one hour of nordic walking. Patients will also be recommended to do at least one more session on their own during the week to match with the American College of sports medicine (ACSM) guidelines for cardiac patients.

Group 2: Participants will have the same supervised intervention for the first 10 weeks and one supervised session will be replaced by an encouragement for autonomous practice of physical activity (written material and regular phone call) in the last 10 weeks.

The follow-up involves participants to answer to the International Physical Activity Questionnaire by phone at baseline, 5, 7 and 9 months. Eventually, they will have to participate to the final evaluation at 12 months for physical and psychological measures.
Primary Outcome(s)
Level of physical activity measured using the International Physical activity questionnaire at baseline, 5, 7, 9 and 12 months.
Secondary Outcome(s)

1. Motivation regarding physical activity is measured using the sport motivation scale at baseline, 5 and 12 months
2. Automaticity of physical activity behaviour is measured using Self Report Behavioral Automaticity Index at baseline, 5 and 12 months
3. Quality of life is measured at baseline, 5 and 12 months
4. Physical condition of the patient is measured using the SF-36 questionnaire at baseline, 5 and 12 months
5. Economic evaluation is measured using The Quality adjusted Life Years (QALY) at baseline, 5 and 12 months
Secondary ID(s)
N/A
Source(s) of Monetary Support
Malakoff Mederick Group
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
1. "Comité de Protection des Personnes" (National ethical committee for human research), 16/12/2014, ref: 14 073 2. "Agence Nationale de la Sécurité et des Médicaments" (National drug agency), 15/12/2014, ref: 141299B-21
Results
Results available: Yes
Date Posted:
Date Completed: 02/02/2016
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history